AbCellera Biologics (ABCL) Selling, General & Administrative (2020 - 2026)
Powered by 
Analysis
AbCellera Biologics (ABCL) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 247.47 Mn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | 13.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.85 Mn |
| Mar 31, 2026 | 12.33 Mn |
| Dec 31, 2025 | 25.98 Mn |
| Sep 30, 2025 | 22.05 Mn |
| Jun 30, 2025 | 21.99 Mn |
| Mar 31, 2025 | 19.07 Mn |
| Dec 31, 2024 | 28.80 Mn |
| Sep 30, 2024 | 19.15 Mn |
| Jun 30, 2024 | 20.19 Mn |
| Mar 31, 2024 | 17.35 Mn |
| Dec 31, 2023 | 30.15 Mn |
| Sep 30, 2023 | 14.37 Mn |
| Jun 30, 2023 | 15.52 Mn |
| Mar 31, 2023 | 15.13 Mn |
| Dec 31, 2022 | 13.02 Mn |
| Sep 30, 2022 | 13.79 Mn |
| Jun 30, 2022 | 14.41 Mn |
| Mar 31, 2022 | 14.27 Mn |
| Dec 31, 2021 | 12.89 Mn |
| Sep 30, 2021 | 11.27 Mn |